LXEO Stock-Based Compensation

Lexeo Therapeutics Inc · Stock-Based Compensation

LXEO logo

LXEO Stock-Based Compensation

Latest reported$13.81M
LXEO Stock-Based Comp ($0.00 → $13.81M)
High-resolution chart · PNG

LXEO stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
12,132,000
12,474,000
3,043,000
1,781,000
386,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.